Facebook Pixel Code
About Sickkids
About SickKids

Martin Offringa, MD, PhD

The Hospital for Sick Children
Staff Neonatologist

Research Institute
Senior Scientist
Child Health Evaluative Sciences

University of Toronto

Phone: 416-813-7654 x28830
Email: martin.offringa@sickkids.ca

For more information, visit:

University of Toronto Profile

Brief Biography

Dr. Offringa is a practicing neonatologist and clinical epidemiologist. His research interests in neonatology are in neonatal hypoglycemia and hyperbilirubinemia, lung protective ventilation and prevention of bronchopulmonary dysplasia. In 2015 he founded Toronto Outcomes Research in Child Health (TORCH), an initiative to develop and measure “core outcome sets” in randomized controlled trials and cohort studies.

Academic Background

Medical School and Residency - Erasmus University, Rotterdam
Fellowship - University of Amsterdam

Research Interests

Clinical Trials, Systematic Reviews, Neonatal Medicine


  1. Cools F, Askie LM, Offringa M, Asselin JM, Calvert SA, Courtney SE, Dani C, Durand DJ, Gerstmann DR, Henderson-Smart DJ, Marlow N, Peacock JL, Pillow JJ, Soll RF,Thome UH, Truffert P, Schreiber MD, van Reempts P, Vendettuoli V, Vento G. Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data. Lancet 2010; 375(9731): 2082-2091.
  2. Hartling L, Wittmeier KD, Caldwell P, van der Lee H, Klassen TP, Craig JC, Offringa M; StaR Child Health Group. StaR child health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials. Pediatrics. 2012 Jun;129 Suppl 3:S112-7. doi: 10.1542/peds.2012-0055C. PMID: 22661756.
  3. Onland W, Debray TP, Laughon MM, Miedema M, Cools F, Askie LM, Asselin JM, Calvert SA, Courtney SE, Dani C, Durand DJ, Marlow N, Peacock JL, Pillow JJ, Soll RF, Thome UH, Truffert P, Schreiber MD, Van Reempts P, Vendettuoli V, Vento G, van Kaam AH, Moons KG, Offringa M. Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC Pediatrics 2013 Dec 17; 13: 207.
  4.  Clyburne-Sherin AV, Thurairajah P, Kapadia MZ, Sampson M, Chan WW, Offringa M. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews. Trials 2015 Sep 18; 16: 417.
  5. Farid-Kapadia M, Joachim KC, Balasingham C, Clyburne-Sherin A, Offringa M. Are child-centric aspects in newborn and child health systematic review and meta-analysis protocols and reports adequately reported? Two systematic reviews. Syst Rev. 2017 Mar 6;6(1):31. doi: 10.1186/s13643-017-0423-9.
  6. Onland W, Cools F, Kroon A, Rademaker K, Merkus MP, Mohns T, Blom H, Marechal Y, Debeer A, Dijk PH, van Heijst AF, Kramer BW, van Straaten HL, Te Pas AB, Theyskens C, Zonnenberg I, Plaskie K, Offringa M, van Kaam AH, on behalf of the SToP-BPD study group. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2019 Jan 29;321(4):354-363. doi: 10.1001/jama.2018.21443.

Visit PubMed for a full list of Dr. Offringa's publications